 In 2016, EteRNA launched its first biomedical challenge called OpenTB, an initiative to develop a new diagnostic device for tuberculosis.The project uses a gene expression "signature" discovered by Stanford researchers using public data, and aims to create an open source, paper-based diagnostic kit that can be easily deployed in clinics around the world.The development of the open source kit is a collaboration with MIT's Little Devices Lab.